Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

In patients with severe aortic stenosis (AS), pulmonary hypertension (PH) typically is
indicative of a decompensated disease state with exhausted compensatory mechanisms of …

Background There are limited data on the prognostic impact of periprocedural pulmonary
hypertension (PH) after transcatheter aortic valve replacement (TAVR). Objectives The aim …

Pulmonary hypertension (PH) is a risk factor for morbidity and mortality in patients
undergoing surgery and anesthesia. This document represents the first international …

BACKGROUND Data on trends, predictors, and outcomes of heart failure (HF) readmissions
after transcatheter aortic valve replacement (TAVR) remain limited. Moreover, the …

Although transcatheter aortic valve implantation (TAVI) has revolutionised the landscape of
treatment for aortic stenosis, there exists a cohort of patients where TAVI is deemed futile …

Patients with severe aortic valve stenosis and concomitant pulmonary hypertension show a
significantly reduced survival prognosis. Right heart catheterization as a preoperative …

Aims There are limited data about the intraprocedural haemodynamic study performed
immediately before and after transcatheter aortic valve implantation (TAVI) in patients with …

Background Pulmonary hypertension (pH) has a prognostic impact on patients undergoing
transcatheter aortic valve replacement (TAVR). Pulmonary artery (PA) dilatation assessed by …

Introduction: Pulmonary hypertension (PH), traditionally defined as a mean pulmonary artery
pressure (PAP)≥ 25 mmHg, is associated with poor outcomes in patients undergoing a …